http://orcid.org/0000-0001-5197-5279
Citations (79)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Juliette Humeau, Julie Le Naour, Lorenzo Galluzzi, Guido Kroemer & Jonathan G. Pol. (2021) Trial watch: intratumoral immunotherapy. OncoImmunology 10:1.
Read now
Read now
Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer & Erika Vacchelli. (2020) Trial watch: TLR3 agonists in cancer therapy. OncoImmunology 9:1.
Read now
Read now
Jibing Chen, Youyong Lv, Feng Mu & Kecheng Xu. (2019) Long-term response of metastatic renal clear cell carcinoma following a subcutaneous injection of mixed bacterial vaccine: a case report. OncoTargets and Therapy 12, pages 2531-2538.
Read now
Read now
Zhiwu Tan, Li Liu, Mei Sum Chiu, Ka-Wai Cheung, Chi Wing Yan, Zhe Yu, Boon Kiat Lee, Wan Liu, Kwan Man & Zhiwei Chen. (2019) Virotherapy-recruited PMN-MDSC infiltration of mesothelioma blocks antitumor CTL by IL-10-mediated dendritic cell suppression. OncoImmunology 8:1.
Read now
Read now
Articles from other publishers (75)
Samik Chakraborty, Juan Ye, Herui Wang, Mitchell Sun, Yaping Zhang, Xueyu Sang & Zhengping Zhuang. (2023) Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy. Frontiers in Immunology 14.
Crossref
Crossref
Alexander Lamoot, Sonia Jangra, Gabriel Laghlali, Prajakta Warang, Gagandeep Singh, Lauren A. Chang, Seok‐Chan Park, Gagandeep Singh, Kim De Swarte, Zifu Zhong, Benoit Louage, Emily De Lombaerde, Tingting Ye, Yong Chen, Sara Cuadrado‐Castano, Stefan Lienenklaus, Niek N. Sanders, Bart N. Lambrecht, Adolfo García‐Sastre, Michael Schotsaert & Bruno G. De Geest. (2023) Lipid Nanoparticle Encapsulation Empowers Poly(I:C) to Activate Cytoplasmic RLRs and Thereby Increases Its Adjuvanticity. Small.
Crossref
Crossref
Carly Butkowsky, Natalie Aldor & Sarah Poynter. (2023) Toll‑like receptor 3 ligands for breast cancer therapies (Review). Molecular and Clinical Oncology 19:2.
Crossref
Crossref
Bo Ju, Nuan-Nuan Xiu, Jia Xu, Xiao-Dong Yang, Xiao-Yun Sun & Xi-Chen Zhao. (2023) Flared inflammatory episode transforms advanced myelodysplastic syndrome into aplastic pancytopenia: A case report and literature review. World Journal of Clinical Cases 11:17, pages 4105-4116.
Crossref
Crossref
A. Lewis, A. Tran, N. L. Aldor, N. A. Jadaa, T. Feng, E. Moore, S. J. DeWitte-Orr & S. J. Poynter. (2023) Phytoglycogen-dsRNA nanoparticles demonstrate differential cytotoxicity and immunostimulatory potential in two ovarian cancer cell lines. Journal of Nanoparticle Research 25:6.
Crossref
Crossref
Huu Thuy Trang Duong, Yue Yin, Thai Minh Duy Le, Ji Hoon Jeong & Doo Sung Lee. (2023) Highly Prolonged Release of the Cancer Vaccine and Immunomodulator via a Two-Layer Biodegradable Microneedle for Prophylactic Treatment of Metastatic Cancer. Biomacromolecules 24:3, pages 1209-1219.
Crossref
Crossref
Chang-Won Lee, Mahesh KC, John M. Ngunjiri, Amir Ghorbani & Kichoon Lee. (2023) TLR3 and MDA5 Knockout DF-1 cells Enhance Replication of Avian Orthoavulavirus 1. Avian Diseases 67:1.
Crossref
Crossref
Jatinder Singh Chera, Sushil Kumar, Amit Kumar Bairagi, Amit Kumar, Prakash Chandra, Ashutosh Vats, Murtaza Ali, Mayank Roshan, Ranjit Singh Kataria & Sachinandan De. (2023) Poly(I:C), a double stranded RNA analog, activates the anti-viral DNA sensors in buffalo fibroblasts. Veterinary Vaccine 2:1, pages 100016.
Crossref
Crossref
Shang Wang, Taiyang Zhu, Wanyan Ni, Chao Zhou, Hui Zhou, Li Lin, Yuting Hu, Xiaoyu Sun, Jingjing Han, Yan Zhou, Guoliang Jin, Jie Zu, Hongjuan Shi, Xingxing Yang, Zuohui Zhang & Fang Hua. (2023) Early activation of Toll-like receptor-3 reduces the pathological progression of Alzheimer’s disease in APP/PS1 mouse. Alzheimer's Research & Therapy 15:1.
Crossref
Crossref
Olga N. Kaplina, Svetlana G. Gamaley, Olga S. Ivanova & Elena D. Danilenko. (2023) Double-stranded RNAs are promising adjuvants for enhancing immunogenicity of vaccines. Journal of microbiology, epidemiology and immunobiology 99:6, pages 661-668.
Crossref
Crossref
Xiong Zou, Yi Guo & Zengnan Mo. (2022) TLR3 serves as a novel diagnostic and prognostic biomarker and is closely correlated with immune microenvironment in three types of cancer. Frontiers in Genetics 13.
Crossref
Crossref
Fan Wu, Yanli Li, Yun Meng, Xuechao Cai, Jieyun Shi, Jinjin Li, Yang Chen, Li Zhang, Xianfu Meng, Huiyan Li, Xingwu Jiang, Zhenxiao Fu, Yelin Wu & Wenbo Bu. (2022) An Ion‐Enhanced Oncolytic Virus‐Like Nanoparticle for Tumor Immunotherapy. Angewandte Chemie International Edition 61:45.
Crossref
Crossref
Fan Wu, Yanli Li, Yun Meng, Xuechao Cai, Jieyun Shi, Jinjin Li, Yang Chen, Li Zhang, Xianfu Meng, Huiyan Li, Xingwu Jiang, Zhenxiao Fu, Yelin Wu & Wenbo Bu. (2022) An Ion‐Enhanced Oncolytic Virus‐Like Nanoparticle for Tumor Immunotherapy. Angewandte Chemie 134:45.
Crossref
Crossref
Run Zheng & Jian Ma. (2022) Immunotherapeutic Implications of Toll-like Receptors Activation in Tumor Microenvironment. Pharmaceutics 14:11, pages 2285.
Crossref
Crossref
Wenjie Zuo, Mai Wakimoto, Noriyasu Kozaiwa, Yutaro Shirasaka, Seong-Wook Oh, Shiori Fujiwara, Hitoshi Miyachi, Amane Kogure, Hiroki Kato & Takashi Fujita. (2022) PKR and TLR3 trigger distinct signals that coordinate the induction of antiviral apoptosis. Cell Death & Disease 13:8.
Crossref
Crossref
Shayla Grace Verburg, Rebecca Margaret Lelievre, Michael James Westerveld, Jordon Marcus Inkol, Yi Lin Sun & Samuel Tekeste Workenhe. (2022) Viral-mediated activation and inhibition of programmed cell death. PLOS Pathogens 18:8, pages e1010718.
Crossref
Crossref
Pei Zhou, Yawen Hu, Xiaoyan Wang, Luxuan Shen, Xinghao Liao, Yajuan Zhu, Jiadong Yu, Fulei Zhao, Yi Zhou, Hengshui Shen & Jiong Li. (2022) Microbiome in cancer: An exploration of carcinogenesis, immune responses and immunotherapy. Frontiers in Immunology 13.
Crossref
Crossref
Hao Zhang, Shuangli Zhu, Wanjun Deng, Rui Li, Haiting Zhou & Huihua Xiong. (2022) The landscape of chimeric antigen receptor T cell therapy in breast cancer: Perspectives and outlook. Frontiers in Immunology 13.
Crossref
Crossref
Lingling Huang, Xiaoyan Ge, Yang Liu, Hui Li & Zhiyue Zhang. (2022) The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy. Pharmaceutics 14:6, pages 1228.
Crossref
Crossref
Chuan Chen, Na Man, Fan Liu, Gloria Mas Martin, Hidehiro Itonaga, Jun Sun & Stephen D. Nimer. (2022) Epigenetic and Transcriptional Regulation of Innate Immunity in Cancer. Cancer Research 82:11, pages 2047-2056.
Crossref
Crossref
Xue Chen, Yunxiao Zhang & Yao Fu. (2022) The critical role of Toll-like receptor-mediated signaling in cancer immunotherapy. Medicine in Drug Discovery 14, pages 100122.
Crossref
Crossref
Weiguang Liu, Peng Sun, Lingling Xia, Xilin He, Zhengmiao Xia, Yehong Huang, Wenzhuo Liu, Lulu Li & Liming Chen. (2022) A brain-enriched lncRNA shields cancer cells from immune-mediated killing for metastatic colonization in the brain. Proceedings of the National Academy of Sciences 119:22.
Crossref
Crossref
Pakorn Sagulkoo, Apichat Suratanee & Kitiporn Plaimas. (2022) Immune-Related Protein Interaction Network in Severe COVID-19 Patients toward the Identification of Key Proteins and Drug Repurposing. Biomolecules 12:5, pages 690.
Crossref
Crossref
Xueqiong Meng, Xiaoxi Cui, Xiaoya Shao, Yanqi Liu, Yihao Xing, Victoria Smith, Shiqiu Xiong, Salvador Macip & Yixiang Chen. (2022) poly(I:C) synergizes with proteasome inhibitors to induce apoptosis in cervical cancer cells. Translational Oncology 18, pages 101362.
Crossref
Crossref
Hassana el Haddaoui, Rianne Brood, Diba Latifi, Astrid A. Oostvogels, Yarne Klaver, Miranda Moskie, Dana A. Mustafa, Reno Debets & Casper H. J. van Eijck. (2022) Rintatolimod (Ampligen®) Enhances Numbers of Peripheral B Cells and Is Associated with Longer Survival in Patients with Locally Advanced and Metastasized Pancreatic Cancer Pre-Treated with FOLFIRINOX: A Single-Center Named Patient Program. Cancers 14:6, pages 1377.
Crossref
Crossref
Monty E. Goldstein & Margaret A. Scull. (2022) Modeling Innate Antiviral Immunity in Physiological Context. Journal of Molecular Biology 434:6, pages 167374.
Crossref
Crossref
Ruixia Wang, Ying Huang, Yan Shi & Zhe Zhao. (2022) Transcriptome Analysis of the Kidney of Obscure Puffer, Takifugu obscurus, Challenged with Poly(I:C). Zoological Science 39:2.
Crossref
Crossref
Asuman Deveci Ozkan, Gamze Guney Eskiler, Suleyman Kaleli & Elvan Sahin. (2021) Immunotherapeutic role of cabazitaxel treatment in the activation of TLR3 signalling in metastatic castration-resistant prostate cancer in vitro. Molecular Biology Reports 49:2, pages 1261-1271.
Crossref
Crossref
Manuel Nico Dold, Xiulin Ng, Claudia Alber, Ian Edward Gentle, Georg Häcker & Arnim Weber. (2022) The deubiquitinase Usp27x as a novel regulator of cFLIPL protein expression and sensitizer to death-receptor-induced apoptosis. Apoptosis 27:1-2, pages 112-132.
Crossref
Crossref
Bassel Akache, Felicity C. Stark, Gerard Agbayani, Tyler M. Renner & Michael J. McCluskie. 2022. Vaccine Design. Vaccine Design
179
231
.
E. M. Kithsiri Wijeratne, Ya-Ming Xu, Manping X. Liu, Marielle C. Inacio, Alan D. Brooks, Poonam Tewary, Thomas J. Sayers & A. A. Leslie Gunatilaka. (2021) Ring A/B-Modified 17β-Hydroxywithanolide Analogues as Antiproliferative Agents for Prostate Cancer and Potentiators of Immunotherapy for Renal Carcinoma and Melanoma. Journal of Natural Products 84:12, pages 3029-3038.
Crossref
Crossref
Ali Bishani & Elena L. Chernolovskaya. (2021) Activation of Innate Immunity by Therapeutic Nucleic Acids. International Journal of Molecular Sciences 22:24, pages 13360.
Crossref
Crossref
Iván Parra‐Izquierdo, Tania Sánchez‐Bayuela, Irene Castaños‐Mollor, Javier López, Cristina Gómez, J. Alberto San Román, Mariano Sánchez Crespo & Carmen García‐Rodríguez. (2021) Clinically used JAK inhibitor blunts dsRNA‐induced inflammation and calcification in aortic valve interstitial cells. The FEBS Journal 288:22, pages 6528-6542.
Crossref
Crossref
Jiangqi Zhao, Xuyan Huang, Patrick Mcleod, Jifu Jiang, Winnie Liu, Aaron Haig, Anthony M. Jevnikar, Zhenyu Jiang & Zhu-Xu Zhang. (2021) Toll-like receptor 3 is an endogenous sensor of cell death and a potential target for induction of long-term cardiac transplant survival. American Journal of Transplantation 21:10, pages 3268-3279.
Crossref
Crossref
Benqing Zhou, Jinxing Liu, Meiai Lin, Jingyi Zhu & Wei R. Chen. (2021) Recent advances in immunotherapy, immunoadjuvant, and nanomaterial-based combination immunotherapy. Coordination Chemistry Reviews 442, pages 214009.
Crossref
Crossref
Melissa M. Pressnall, Aric Huang, Chad E. Groer, Sebastian G. Huayamares, M. Laird Forrest & Cory J. Berkland. (2021) Glatiramer acetate enhances tumor retention and innate activation of immunostimulants. International Journal of Pharmaceutics 605, pages 120812.
Crossref
Crossref
Asma Komal, Mamoona Noreen & Attalla F. El-Kott. (2021) TLR3 agonists: RGC100, ARNAX, and poly-IC: a comparative review. Immunologic Research 69:4, pages 312-322.
Crossref
Crossref
Brian Fiani, Athanasios Kondilis, Marisol Soula, Anthony Tao & Mohammed Ali Alvi. (2021) Novel Methods of Necroptosis Inhibition for Spinal Cord Injury Using Translational Research to Limit Secondary Injury and Enhance Endogenous Repair and Regeneration. Neurospine 18:2, pages 261-270.
Crossref
Crossref
Poonam Tewary, Alan D. Brooks, Ya-Ming Xu, E.M. Kithsiri Wijeratne, Ashley L. Babyak, Timothy C. Back, Raj Chari, Christine N. Evans, Curtis J. Henrich, Thomas J. Meyer, Elijah F. Edmondson, Maria T. Prudente de Aquino, Thanigaivelan Kanagasabai, Anil Shanker, A.A. Leslie Gunatilaka & Thomas J. Sayers. (2021) Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET Proteins. Cancer Research 81:12, pages 3374-3386.
Crossref
Crossref
Jun Dai, Meng Wu, Quan Wang, Siyang Ding, Xiaoqi Dong, Liru Xue, Qingqing Zhu, Jian Zhou, Fan Xia, Shixuan Wang & Yuning Hong. (2021) Red blood cell membrane-camouflaged nanoparticles loaded with AIEgen and Poly(I : C) for enhanced tumoral photodynamic-immunotherapy. National Science Review 8:6.
Crossref
Crossref
Saghar Pahlavanneshan, Ali Sayadmanesh, Hamidreza Ebrahimiyan & Mohsen Basiri. (2021) Toll-Like Receptor-Based Strategies for Cancer Immunotherapy. Journal of Immunology Research 2021, pages 1-14.
Crossref
Crossref
Julia Koerner, Dennis Horvath, Valerie L. Herrmann, Anna MacKerracher, Bruno Gander, Hideo Yagita, Jacques Rohayem & Marcus Groettrup. (2021) PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy. Nature Communications 12:1.
Crossref
Crossref
Pashayar P. Lookian, David Zhao, Rogelio Medina, Herui Wang, Jan Zenka, Mark R. Gilbert, Karel Pacak & Zhengping Zhuang. (2021) Mannan-BAM, TLR Ligands, Anti-CD40 Antibody (MBTA) Vaccine Immunotherapy: A Review of Current Evidence and Applications in Glioblastoma. International Journal of Molecular Sciences 22:7, pages 3455.
Crossref
Crossref
Matylda Barbara Mielcarska, Magdalena Bossowska-Nowicka & Felix Ngosa Toka. (2021) Cell Surface Expression of Endosomal Toll-Like Receptors—A Necessity or a Superfluous Duplication?. Frontiers in Immunology 11.
Crossref
Crossref
Yona Keisari & Itzhak Kelson. (2021) The Potentiation of Anti-Tumor Immunity by Tumor Abolition with Alpha Particles, Protons, or Carbon Ion Radiation and Its Enforcement by Combination with Immunoadjuvants or Inhibitors of Immune Suppressor Cells and Checkpoint Molecules. Cells 10:2, pages 228.
Crossref
Crossref
Thanpisit Lomphithak, Swati Choksi, Apiwat Mutirangura, Rutaiwan Tohtong, Tewin Tencomnao, Hajime Usubuchi, Michiaki Unno, Hironobu Sasano & Siriporn Jitkaew. (2020) Receptor-interacting protein kinase 1 is a
key mediator in TLR3 ligand and Smac mimetic-induced cell death and suppresses TLR3
ligand-promoted invasion in cholangiocarcinoma. Cell Communication and Signaling 18:1.
Crossref
Crossref
Simone Hager, Frederic Julien Fittler, Ernst Wagner & Matthias Bros. (2020) Nucleic Acid-Based Approaches for Tumor Therapy. Cells 9:9, pages 2061.
Crossref
Crossref
Melissa M. Pressnall, Sebastian G. Huayamares & Cory J. Berkland. (2020) Immunostimulant Complexed With Polylysine Limits Transport and Maintains Immune Cell Activation. Journal of Pharmaceutical Sciences 109:9, pages 2836-2846.
Crossref
Crossref
Vishwaratn Asthana, Brett S. Stern, Yuqi Tang, Pallavi Bugga, Ang Li, Adam Ferguson, Anantratn Asthana, Gang Bao & Rebekah A. Drezek. (2020) Development of a Novel Class of Self-Assembling dsRNA Cancer Therapeutics: A Proof-of-Concept Investigation. Molecular Therapy - Oncolytics 18, pages 419-431.
Crossref
Crossref
Rogelio Medina, Herui Wang, Veronika Caisová, Jing Cui, Iris H. Indig, Ondrej Uher, Juan Ye, Anthony Nwankwo, Victoria Sanchez, Tianxia Wu, Edjah Nduom, John Heiss, Mark R. Gilbert, Masaki Terabe, Winson Ho, Jan Zenka, Karel Pacak & Zhengping Zhuang. (2020) Induction of Immune Response against Metastatic Tumors via Vaccination of Mannan‐BAM, TLR Ligands, and Anti‐CD40 Antibody (MBTA). Advanced Therapeutics 3:9, pages 2000044.
Crossref
Crossref
Vered Domankevich, Margalit Efrati, Michael Schmidt, Eran Glikson, Fairuz Mansour, Amit Shai, Adi Cohen, Yael Zilberstein, Elad Flaisher, Razvan Galalae, Itzhak Kelson & Yona Keisari. (2020) RIG-1-Like Receptor Activation Synergizes With Intratumoral Alpha Radiation to Induce Pancreatic Tumor Rejection, Triple-Negative Breast Metastases Clearance, and Antitumor Immune Memory in Mice. Frontiers in Oncology 10.
Crossref
Crossref
Hyun-Jun Jang & Ki-Duk Song. (2020) Expression patterns of innate immunity-related genes in response to
polyinosinic:polycytidylic acid (poly[I:C]) stimulation in DF-1 chicken
fibroblast cells. Journal of Animal Science and Technology 62:3, pages 385-395.
Crossref
Crossref
Dagmar Stoiber & Alice Assinger. (2020) Platelet-Leukocyte Interplay in Cancer Development and Progression. Cells 9:4, pages 855.
Crossref
Crossref
Tiziana Di Marco, Francesca Bianchi, Lucia Sfondrini, Katia Todoerti, Italia Bongarzone, Elisa Margherita Maffioli, Gabriella Tedeschi, Mara Mazzoni, Sonia Pagliardini, Sandra Pellegrini, Antonino Neri, Maria Chiara Anania & Angela Greco. (2020) COPZ1 depletion in thyroid tumor cells triggers type I IFN response and immunogenic cell death. Cancer Letters 476, pages 106-119.
Crossref
Crossref
Sandra Santos-Sierra. (2020) Developments in anticancer vaccination: budding new adjuvants. Biological Chemistry 401:4, pages 435-446.
Crossref
Crossref
Francesca Bianchi, Spyridon Alexiadis, Chiara Camisaschi, Mauro Truini, Giovanni Centonze, Massimo Milione, Andrea Balsari, Elda Tagliabue & Lucia Sfondrini. (2020) TLR3 Expression Induces Apoptosis in Human Non-Small-Cell Lung Cancer. International Journal of Molecular Sciences 21:4, pages 1440.
Crossref
Crossref
Yingcheng Zheng, Guoguo Zhu, Yinglian Tang, Jun Yan, Song Han, Jun Yin, Biwen Peng, Xiaohua He & Wanhong Liu. (2020) HDAC6, A Novel Cargo for Autophagic Clearance of Stress Granules, Mediates the Repression of the Type I Interferon Response During Coxsackievirus A16 Infection. Frontiers in Microbiology 11.
Crossref
Crossref
Navaz Karimian Pour, Eliza R. McColl & Micheline Piquette-Miller. (2019) Impact of Viral Inflammation on the Expression of Renal Drug Transporters in Pregnant Rats. Pharmaceutics 11:12, pages 624.
Crossref
Crossref
H.M. Kowash, H.G. Potter, M.E. Edye, E.P. Prinssen, S. Bandinelli, J.C. Neill, R. Hager & J.D. Glazier. (2019) Poly(I:C) source, molecular weight and endotoxin contamination affect dam and prenatal outcomes, implications for models of maternal immune activation. Brain, Behavior, and Immunity 82, pages 160-166.
Crossref
Crossref
Junjing Wu, Ziyun Ji, Mu Qiao, Xianwen Peng, Huayu Wu, Zhongxu Song, Haizhong Zhao, Guisheng Liu, Fenge Li & Shuqi Mei. (2019) MicroRNA transcriptome analysis of poly I:C-stimulated and PRRSV-infected porcine alveolar macrophages. Journal of Applied Genetics 60:3-4, pages 375-383.
Crossref
Crossref
E. M. Treshalina, I. N. Mikhaylova & M. V. Kiselevskiy. (2019) The different roles of toll-like receptors in oncotherapy. Russian Journal of Biotherapy 18:3, pages 15-22.
Crossref
Crossref
Francesca Bianchi, Massimo Milione, Patrizia Casalini, Giovanni Centonze, Valentino M. Le Noci, Chiara Storti, Spyridon Alexiadis, Mauro Truini, Gabriella Sozzi, Ugo Pastorino, Andrea Balsari, Elda Tagliabue & Lucia Sfondrini. (2019) Toll-like receptor 3 as a new marker to detect high risk early stage Non-Small-Cell Lung Cancer patients. Scientific Reports 9:1.
Crossref
Crossref
E. D. Danilenko, A. O. Belkina & G. M. Sysoeva. (2019) Development of Drugs Based on High-Polymeric Double-Stranded RNA for Antiviral and Antitumor Therapy. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry 13:4, pages 308-323.
Crossref
Crossref
Xin Xie, Martin Endara-Coll, Raza Mahmood, Robertas Jankauskas, Tamara Gjorgjieva & Piergiorgio Percipalle. (2019) Mitochondria-localized β-actin is essential for priming innate antiviral immune signaling by regulating IRF3 protein stability. Cellular & Molecular Immunology 16:10, pages 837-840.
Crossref
Crossref
E.D. Danilenko, A.O. Belkina & G.M. Sysoeva. (2019) Development of drugs on the basis of high-polymeric double-stranded RNA for antiviral and antitumor therapy. Biomeditsinskaya Khimiya 65:4, pages 277-293.
Crossref
Crossref
Chaohao Huang, Shengchuan Chen, Tan Zhang, Dapei Li, Zhonglin Huang, Jian Huang, Yanghua Qin, Bicheng Chen, Genhong Cheng, Feng Ma & Mengtao Zhou. (2019) TLR3 Ligand PolyI:C Prevents Acute Pancreatitis Through the Interferon-β/Interferon-α/β Receptor Signaling Pathway in a Caerulein-Induced Pancreatitis Mouse Model. Frontiers in Immunology 10.
Crossref
Crossref
Jiaojiao Zhao, Yaxian Xue, Yuchen Pan, Anran Yao, Guoqun Wang, Dan Li, Tingting Wang, Shuli Zhao & Yayi Hou. (2018) Toll‐like receptor 3 agonist poly I:C reinforces the potency of cytotoxic chemotherapy via the TLR3‐UNC93B1‐IFN‐β signaling axis in paclitaxel‐resistant colon cancer. Journal of Cellular Physiology 234:5, pages 7051-7061.
Crossref
Crossref
Ragan Pitner, Jiho Kim, Jenn Davis-Bergthold, Cheri Turner, Emilie Vassal-Stermann, Hongjie Wang, Jaclyn Adams, Lauren Carter, Jeffrey A. Ahlgren, Pascal Fender, André Lieber, Darrick Carter & Sean A. Gray. (2019) Structure-based Design of JOC-x, a Conjugatable Tumor Tight Junction Opener to Enhance Cancer Therapy. Scientific Reports 9:1.
Crossref
Crossref
Nguyen T.K. Vo, Levi C. Moore, Eric Leis & Stephanie J. DeWitte-Orr. (2019) Class A scavenger receptors mediate extracellular dsRNA sensing, leading to downstream antiviral gene expression in a novel American toad cell line, BufoTad. Developmental & Comparative Immunology 92, pages 140-149.
Crossref
Crossref
David J. Flavell, Suzanne E. Holmes, Sarah L Warnes & Sopsamorn U. Flavell. (2019) The TLR3 Agonist Poly Inosinic:Cytidylic Acid Significantly Augments the Therapeutic Activity of an Anti-CD7 Immunotoxin for Human T-cell Leukaemia. Biomedicines 7:1, pages 13.
Crossref
Crossref
Martina Mikulandra, Antonio Kobescak, Benjamin Verillaud, Pierre Busson & Tanja Matijevic Glavan. (2018) Radio-sensitization of head and neck cancer cells by a combination of poly(I:C) and cisplatin through downregulation of survivin and c-IAP2. Cellular Oncology 42:1, pages 29-40.
Crossref
Crossref
Mohamed A. Anany, Jennifer Kreckel, Simone Füllsack, Alevtina Rosenthal, Christoph Otto, Daniela Siegmund & Harald Wajant. (2018) Soluble TNF-like weak inducer of apoptosis (TWEAK) enhances poly(I:C)-induced RIPK1-mediated necroptosis. Cell Death & Disease 9:11.
Crossref
Crossref
Fernando Pastor, Pedro Berraondo, Iñaki Etxeberria, Josh Frederick, Ugur Sahin, Eli Gilboa & Ignacio Melero. (2018) An RNA toolbox for cancer immunotherapy. Nature Reviews Drug Discovery 17:10, pages 751-767.
Crossref
Crossref
Xiaohong Cen, Shuwen Liu & Kui Cheng. (2018) The Role of Toll-Like Receptor in Inflammation and Tumor Immunity. Frontiers in Pharmacology 9.
Crossref
Crossref
Connie Wu, Jiahe Li, Wade Wang & Paula T. Hammond. (2018) Rationally Designed Polycationic Carriers for Potent Polymeric siRNA-Mediated Gene Silencing. ACS Nano 12:7, pages 6504-6514.
Crossref
Crossref